Literature DB >> 17219980

Inhibition of cell growth and telomerase activity in osteosarcoma cells by DN-hTERT.

Tao Xu1, Yaojian Rao, Wentao Zhu, Fengjin Guo.   

Abstract

In order to study the effects of dominant negative human telomerase reverse transcriptase (DN-hTERT) on cell growth and telomerase activity in osteosarcoma cell line MG63, MG63 cells were transfected with DN-hTERT-IRES2-EGFP9 (DN) or IRES2-EGF (I, blank vector) with lipofectamine 2000. The stably transfected cells were selected with G-418. Cell growth properties were examined under a fluorescence microscope. The hTERT mRNA expression was detected by reverse transcription-polymerase chain reaction (RT-PCR). Telomerase activities were measured by TRAP-ELISE. The tumorigenicity was studied with tumor xenografts by subcutaneous injection of cancer cells into nude mice. The results showed that cell growth was suppressed in MG63 cells transfected with DN-hTERT. The hTERT mRNA was increased in N-hTERT transfected-MG63 cells (MG63/DN). The telomerase activity was 2.45-0.11 in MG63/DN cells, while 3.40+/-0.12 in the cells transfected with blank vector (MG63/I), (P<0.05); DN-hTERT-expressing clones did not form tumors in 2 weeks, but the ratio of tumorigenesis was 30 % in nude mice bearing MG63/I (P<0.01). It was concluded that DN-hTERT could specifically inhibit the cell growth and telomerase activity in MG63 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17219980     DOI: 10.1007/s11596-006-0532-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  11 in total

Review 1.  Telomerase and malignant transformation.

Authors:  Jiamei Yu; Louis Dubeau
Journal:  Cancer Treat Res       Date:  2002

2.  p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

Authors:  L Chin; S E Artandi; Q Shen; A Tam; S L Lee; G J Gottlieb; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

3.  A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo.

Authors:  J E Mata; S S Joshi; B Palen; S J Pirruccello; J D Jackson; N Elias; T J Page; K L Medlin; P L Iversen
Journal:  Toxicol Appl Pharmacol       Date:  1997-05       Impact factor: 4.219

4.  Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.

Authors:  Chung-Ping Hsu; Nan-Yuan Hsu; Li-Wen Lee; Jiunn-Liang Ko
Journal:  Eur J Cancer       Date:  2006-06-05       Impact factor: 9.162

5.  Telomerase in anti-tumor response.

Authors:  Tanja Batinac; Gordana Zamolo; Ita Hadzisejdic
Journal:  Med Hypotheses       Date:  2006-08-28       Impact factor: 1.538

6.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

Review 7.  Telomerase and telomeres: from basic biology to cancer treatment.

Authors:  Marco N Helder; G Bea A Wisman; G J van der Zee
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

8.  The RNA component of human telomerase.

Authors:  J Feng; W D Funk; S S Wang; S L Weinrich; A A Avilion; C P Chiu; R R Adams; E Chang; R C Allsopp; J Yu
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

9.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

Review 10.  Telomeres and telomerase: Pharmacological targets for new anticancer strategies?

Authors:  F Pendino; I Tarkanyi; C Dudognon; J Hillion; M Lanotte; J Aradi; E Ségal-Bendirdjian
Journal:  Curr Cancer Drug Targets       Date:  2006-03       Impact factor: 3.428

View more
  3 in total

1.  Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor.

Authors:  Xun Jin; Samuel Beck; Young-Woo Sohn; Jun-Kyum Kim; Sung-Hak Kim; Jinlong Yin; Xumin Pian; Sung-Chan Kim; Yun-Jaie Choi; Hyunggee Kim
Journal:  Exp Mol Med       Date:  2010-08-31       Impact factor: 8.718

2.  Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity.

Authors:  Ling Yu; Shiqing Liu; Chun Zhang; Bo Zhang; Bruno M Simões; Rachel Eyre; Yi Liang; Huichao Yan; Zheng Wu; Weichun Guo; Robert B Clarke
Journal:  Oncotarget       Date:  2013-12

3.  Telomere Transcripts Target Telomerase in Human Cancer Cells.

Authors:  Theresa Kreilmeier; Doris Mejri; Marlene Hauck; Miriam Kleiter; Klaus Holzmann
Journal:  Genes (Basel)       Date:  2016-08-16       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.